Susquehanna Portfolio Strategies’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,427
Closed -$76.2K 969
2025
Q4
$76.2K Sell
4,427
-17,012
-79% -$330K ﹤0.01% 984
2025
Q3
$552K Buy
21,439
+5,155
+32% +$195K 0.01% 813
2025
Q2
$936K Buy
+16,284
New +$1.31M 0.02% 521

Other funds holding AGL

Susquehanna Portfolio Strategies's AGL Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 4,427 shares — an estimated $76.2K sold.

Susquehanna Portfolio Strategies first reported a position in AGL in Q2 2025 and held it in 3 quarters. The position peaked at $936K in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 4,427 Agilon Health shares in Q1 2026, an estimated $76.2K.
  • Susquehanna Portfolio Strategies first reported a position in Agilon Health in Q2 2025 and held it in 3 quarters.
  • Susquehanna Portfolio Strategies's Agilon Health position peaked at $936K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.